Melperone treatment in an organic delusional syndrome induced by hyperprolactinemia: a case report.
A young female with organic delusional syndrome induced by hyperprolactinemia was admitted to the Psychiatry Clinic of Ankara Social Security Hospital. The most striking characteristic of her history was either worsening of the endocrinologic clinical outcome under conventional neuroleptic treatment or worsening of clinical psychiatric outcome under bromocriptine therapy. A new atypical neuroleptic, melperone, suggested to minimally affect plasma prolactin levels, was started. Her psychotic complaints significantly subsided and she was devoid of any symptomatological change regarding her endocrinological status. These results were discussed.
Soygür
H
H
Ankara Social Security Hospital, Clinics of Psychiatry and Neurosurgery, Turkey.
Palaoğlu
O
O
Altinörs
N
N
Corapçioğlu
D
D
Erdoğan
G
G
Ayhan
I H
IH
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002090:Butyrophenones / Q000627:therapeutic use*; D003702:Delusions / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000503:physiopathology*
D014150:Antipsychotic Agents; D002090:Butyrophenones; C008522:metylperon